BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17504903)

  • 1. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
    Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient testicular warming enhances the suppressive effect of testosterone on spermatogenesis in adult cynomolgus monkeys (Macaca fascicularis).
    Lue Y; Wang C; Liu YX; Hikim AP; Zhang XS; Ng CM; Hu ZY; Li YC; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2006 Feb; 91(2):539-45. PubMed ID: 16317056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development.
    Lue Y; Hikim AP; Wang C; Im M; Leung A; Swerdloff RS
    Endocrinology; 2000 Apr; 141(4):1414-24. PubMed ID: 10746645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
    Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.
    Gui YL; He CH; Amory JK; Bremner WJ; Zheng EX; Yang J; Yang PJ; Gao ES
    J Androl; 2004; 25(5):720-7. PubMed ID: 15292101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.
    Wang C; Wang XH; Nelson AL; Lee KK; Cui YG; Tong JS; Berman N; Lumbreras L; Leung A; Hull L; Desai S; Swerdloff RS
    J Clin Endocrinol Metab; 2006 Feb; 91(2):460-70. PubMed ID: 16278260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild testicular hyperthermia induces profound transitional spermatogenic suppression through increased germ cell apoptosis in adult cynomolgus monkeys (Macaca fascicularis).
    Lue YH; Lasley BL; Laughlin LS; Swerdloff RS; Hikim AP; Leung A; Overstreet JW; Wang C
    J Androl; 2002; 23(6):799-805. PubMed ID: 12399525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men.
    Lue Y; Wang C; Cui Y; Wang X; Sha J; Zhou Z; Xu J; Wang C; Hikim AP; Swerdloff RS
    Biol Reprod; 2009 Mar; 80(3):484-92. PubMed ID: 19074003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel.
    Ilani N; Armanious N; Lue YH; Swerdloff RS; Baravarian S; Adler A; Tsang C; Jia Y; Cui YG; Wang XH; Zhou ZM; Sha JH; Wang C
    Hum Reprod; 2012 Dec; 27(12):3403-11. PubMed ID: 23019303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
    Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
    J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
    Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
    Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
    Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
    Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ
    Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
    Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
    J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.
    Meriggiola MC; Costantino A; Cerpolini S; Bremner WJ; Huebler D; Morselli-Labate AM; Kirsch B; Bertaccini A; Pelusi C; Pelusi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5818-26. PubMed ID: 14671175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive.
    Cui Y; Zhu H; Zhu Y; Guo X; Huo R; Wang X; Tong J; Qian L; Zhou Z; Jia Y; Lue YH; Hikim AS; Wang C; Swerdloff RS; Sha J
    J Proteome Res; 2008 Sep; 7(9):3984-93. PubMed ID: 18702538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.